Evaluating candidate agents of selective pressure for cystic fibrosis

Journal of the Royal Society Interface

Volumn 4, Issue 12, 2007, Pages 91-98

  Poolman, Eric M ^a   Galvani, Alison P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cholera; Cystic fibrosis; Heterozygote advantage; Tuberculosis; Typhoid fever

Indexed keywords

ARTICLE; CHOLERA; CYSTIC FIBROSIS; EUROPE; GENETIC MODEL; HETEROZYGOSITY; HUMAN; INCIDENCE; MORTALITY; TUBERCULOSIS; TYPHOID FEVER;

EID: 33846868412     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2006.0154     Document Type: Article

References (66)

1. Albert, M. J., Faruque, A. S., Faruque, S. M., Sack, R. B. & Mahalanabis, D. 1999 Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J. Clin. Microbiol. 37, 3458-3464.
2. Anderson, C. M., Allan, J. & Johansen, P. G. 1967 Comments on the possible existence and nature of a heterozygote advantage in cystic fibrosis. Bibl. Paediatr. 86, 381-387.
3. Barua, D. 1992 History of Cholera. In Cholera (ed. D. Barua & W. Greenough), pp. 1-36. New York, NY: Plenum Medical Book Company.
4. Bates, J. H. & Stead, W. W. 1993 The history of tuberculosis as a global epidemic. In The medical clinics of North America: tuberculosis, vol. 77 (ed. J. B. Bass), pp. 1205-1217. Harcourt Brace & Company: Philadelphia.
5. Bertranpetit, J. & Calafell, F. 1996 Genetic and geographical variability in cystic fibrosis: evolutionary considerations. Ciba Found. Symp. 197, 97-114 discussion 114-8
6. Bobadilla, J. L., Macek Jr, M., Fine, J. P. & Farrell, P. M. 2002 Cystic fibrosis: a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Hum. Mutat. 19, 575-606. (doi:10. 1002/humu.10041)
7. Chao, A. C., de Sauvage, F. J., Dong, Y. J., Wagner, J. A., Goeddel, D. V. & Gardner, P. 1994 Activation of intestinal CFTR Cl-channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J. 13, 1065-1072.
8. Crawfurd, M. A., 1972 A genetic study, including evidence for heterosis, of cystic fibrosis of the pancreas. In 168th Meeting of the Genetical Society of Great Britain, pp. 126. University of Leeds.
9. Creighton, C. 1965 A history of epidemics in Britain. London, UK: Cass.
10. Crow, J. F. 1979 Gene frequency and fitness change in an age-structured population. Ann. Hum. Genet. 42, 355-370.
11. Crump, J. A., Luby, S. P. & Mintz, E. D. 2004 The global burden of typhoid fever. Bull. World Health Organ. 82, 346-353.
12. Cuppens, H. et al. 1998 Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J. Clin. Invest. 101, 487-496.
13. Cuthbert, A. W., Halstead, J., Ratcliff, R., Colledge, W. H. & Evans, M. J. 1995 The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J. Physiol. 482, (Pt 2) 449-454.
14. Cuthbert, A. W., Hickman, M. E., MacVinish, L. J., Evans, M. J., Colledge, W. H., Ratcliff, R., Seale, P. W. & Humphrey, P. P. 1994 Chloride secretion in response to guanylin in colonic epithelial from normal and transgenic cystic fibrosis mice. Br. J. Pharmacol. 112, 31-36.
15. Cystic Fibrosis Genetic Analysis Consortium 2005 Cystic Fibrosis Mutation Database. See http://www.genet. sickkids.on.ca/cftr/.
16. Davis, A. L. 2000 History of Tuberculosis. In Tuberculosis: a comprehensive international approach (ed. L. B. Reichman & E. S. Hershfield), pp. 3-54. New York, NY: Marcel Dekker, Inc.
17. Freeman, S. & Herron, J. C. 2004 Evolutionary analysis. Upper Saddle River, NJ: Pearson Prentice Hall.
18. Frossard, P. M., Girodon, E., Dawson, K. P., Ghanem, N., Plassa, F., Lestringant, G. G. & Goossens, M. 1998 Identification of cystic fibrosis mutations in the United Arab Emirates. Mutations in brief no. 133. Online. Hum. Mutat. 11, 412-413. (doi:10.1002/(SICI)1098-1004(1998) 11:5〈412::AID-HUMU15〉3.0.CO;2-O)
19. Fujiki, K. et al. 2004 Genetic evidence for CFTR dysfunction in Japanese: background for chronic pancreatitis. J. Med. Genet. 41, e55. (doi:10.1136/jmg.2003.014456)
20. Gabriel, S. E., Brigman, K. N., Koller, B. H., Boucher, R. C. & Stutts, M. J. 1994 Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266, 107-109.
21. Galvani, A. P. &: Slatkin, M. 2003 Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proc. Natl Acad. Sci. USA 100, 15 276-15 279. (doi:10.1073/pnas. 2435085100)
22. Galvani, A. P. & Slatkin, M. 2004 Intense selection in an age-structured population. Proc. R. Soc. B 271, 171-176. (doi:10.1098/rspb.2003.2573)
23. Goldstein, J. L., Sahi, J., Bhuva, M., Layden, T. J. & Rao, M. C. 1994 Escherichia coli heat-stable enterotoxin-mediated colonic Cl-secretion is absent in cystic fibrosis. Gastroenterology 107, 950-956.
24. Goren, M. B., D'Arcy Hart, P., Young, M. R. & Armstrong, J. A. 1976 Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 73, 2510-2514. (doi:10.1073/pnas.73.7.2510)
25. Grigg, E. R. 1958 The arcana of tuberculosis with a brief epidemiologic history of the disease in the U.S.A. Am. Rev. Tuberc. 78, 151-172.
26. Hansson, G. C. 1988 Cystic fibrosis and chloride-secreting diarrhoea. Nature 333, 711. (doi:10.1038/333711c0)
27. Heberden, W. & Percival, T. 1973 Population and disease in early industrial England. Pioneers of demography. Farnborough, UK: Gregg.
28. Hjelte, L., Petrini, B., Kallenius, G. & Strandvik, B. 1990 Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax 45, 397-400.
29. Hogenauer, C., Santa Ana, C. A., Porter, J. L., Millard, M., Gelfand, A., Rosenblatt, R. L., Prestidge, C. B. & Fordtran, J. S. 2000 Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am. J. Hum. Genet. 67, 1422-1427. (doi:10.1086/316911)
30. Hughes, A. L., Friedman, R. & Murray, M. 2002 Genomewide pattern of synonymous nucleotide substitution in two complete genomes of Mycobacterium tuberculosis. Emerg. Infect. Dis. 8, 1342-1346.
31. Kapur, V., Whittam, T. S. & Musser, J. M. 1994 Is Mycobacterium tuberculosis 15 000 years old? J. Infect. Dis. 170, 1348-1349.
32. Kerem, B., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M. & Tsui, L. C. 1989 Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073-1080.
33. Kilby, J. M., Gilligan, P. H., Yankaskas, J. R., Highsmith Jr, W. E., Edwards, L. J. & Knowles, M. R. 1992 Non-tuberculous mycobacteria in adult patients with cystic fibrosis. Chest 102, 70-75.
34. Kipple, K. 1993 The Cambridge world history of human disease. Cambridge, UK: Cambridge University Press.
35. Klinger, K. W. 1983 Cystic fibrosis in the Ohio Amish: gene frequency and founder effect. Hum. Genet. 65, 94-98. (doi:10.1007/BF00286641)
36. Macek Jr, M. et al. 1997 Possible association of the allele status of the CS.7/HhaI polymorphism 5′ of the CFTR gene with postnatal female survival. Hum. Genet. 99, 565-572. (doi:10.1007/s004390050407)
37. Meindl, R. S. 1987 Hypothesis: a selective advantage for cystic fibrosis heterozygotes. Am. J. Phys. Anthropol. 74, 39-45. (doi:10.1002/ajpa.1330740104)
38. Morral, N. et al. 1994 The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nat. Genet. 7, 169-175. (doi:10.1038/ng0694-169)
39. Morris, A. P., Whittaker, J. C. & Balding, D. J. 2002 Fine-scale mapping of disease loci via shattered coalescent modeling of genealogies. Am. J. Hum. Genet. 70, 686-707. (doi:10.1086/339271)
40. Morse, D., Brothwell, D. R. & Ucko, P. J. 1964 Tuberculosis in Ancient Egypt. Am. Rev. Respir. Dis. 90, 524-541.
41. Nishino, J. & Tajima, F. 2005 Effect of population structure on the amount of polymorphism and the fixation probability under overdominant selection. Genes Genet. Syst. 80, 287-295. (doi:10.1266/ggs.80. 287)
42. Nunn, P., Williams, B., Floyd, K., Dye, C., Elzinga, G. & Raviglione, M. 2005 Tuberculosis control in the era of HIV. Nat. Rev. Immunol. 5, 819-826. (doi:10.1038/nri1704)
43. Pier, G. B., Grout, M., Zaidi, T., Meluleni, G., Mueschenborn, S. S., Banting, G., Ratcliff, R., Evans, M. J. & Colledge, W. H. 1998 Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393, 79-82. (doi:10.1038/30006)
44. Powers, C. A., Potter, E. M., Wessel, H. U. & Lloyd-Still, J. D. 1996 Cystic fibrosis in Asian Indians. Arch. Pediatr. Adolesc. Med. 150, 554-555.
45. Preston, S. H., Heuveline, P. & Guillot, M. 2001 Demography: measuring and modeling population processes. Oxford, UK: Blackwell Publishers Ltd.
46. Riordan, J. R. et al. 1989 Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073.
47. Rivera-Marrero, C. A., Ritzenthaler, J. D., Newburn, S. A., Roman, J. & Cummings, R. D. 2002 Molecular cloning and expression of a novel glycolipid sulfotransferase in Mycobacterium tuberculosis. Microbiology 148, 783-792.
48. Romeo, G., Devoto, M. & Galietta, L. J. 1989 Why is the cystic fibrosis gene so frequent? Hum. Genet. 84, 1-5. (doi:10.1007/BF00210660)
49. Rommens, J. M. et al. 1989 Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245, 1059-1065.
50. Rothschild, B. M., Martin, L. D., Lev, G., Bercovier, H., Bar-Gal, G. K., Greenblatt, C., Donoghue, H., Spigelman, M. & Brittain, D. 2001 Mycobacterium tuberculosis complex DNA from an extinct bison dated 17 000 years before the present. Clin. Infect. Dis. 33, 305-311. (doi:10. 1086/321886)
51. Samuelson, P. A. 1978 Generalizing Fisher's "reproductive value": overlapping and nonoverlapping generations with competing genotypes. Proc. Natl Acad. Sci. USA 75, 4062-4066. (doi:10.1073/pnas.75.8.4062)
52. Sereth, H., Shoshani, T., Bashan, N. & Kerem, B. S. 1993 Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis. Hum. Genet. 92, 289-295. (doi:10.1007/BF00244474)
53. Serre, J. L., Simon-Bouy, B., Mornet, E., Jaume-Roig, B., Balassopoulou, A., Schwartz, M., Taillandier, A., Boue, J. & Boue, A. 1990 Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics. Hum. Genet. 84, 449-454. (doi:10.1007/BF00195818)
54. Sharer, N., Schwarz, M., Malone, G., Howarth, A., Painter, J., Super, M. & Braganza, J. 1998 Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N. Engl. J. Med. 339, 645-652. (doi:10.1056/NEJM 199809033391001)
55. Sinha, A. et al. 1999 Typhoid fever in children aged less than 5 years. Lancet 354, 734-737. (doi:10.1016/S0140-6736(98) 09001-1)
56. Smith, M. J., Efthimiou, J., Hodson, M. E. & Batten, J. C. 1984 Mycobacterial isolations in young adults with cystic fibrosis. Thorax 39, 369-375.
57. Tobacman, J. K. 2003 Does deficiency of arylsulfatase B have a role in cystic fibrosis? Chest 123, 2130-2139. (doi:10. 1378/chest.123.6.2130)
58. Twelfth Annual Report 1854 Twelfth annual report relating to the registry of births, marriages, and deaths in Massachusetts. In From consumption to tuberculosis: a documentary history (ed. B. Gutmann Rosenkrantz). New York, NY: Garland.
59. van de Vosse, E., Ali, S., Visser, A. W., Surjadi, C., Widjaja, S., Vollaard, A. M. & Dissel, J. T. 2005 Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR). Hum. Genet., 1-3.
60. Warwick, W. J. & Monson, S. 1967 Life table studies of mortality. Bibl. Paediatr. 86, 353-367.
61. Welsh, M. J., Ramsey, B. W., Accurso, F. & Cutting, G. R. 2001 Cystic fibrosis. In The metabolic and molecular bases of inherited disease (ed. C. R. Scriver, A. L. Beaudet, D. Valle, W. S. Sly, B. Vogelstein, B. Childs & K. W. Kinzler). New York, NY: McGraw-Hill.
62. Wirth, B., Schmidt, T., Hahnen, E., Rudnik-Schoneborn, S., Krawczak, M., Muller-Myhsok, B., Schonling, J. & Zerres, K. 1997 De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am. J. Hum. Genet. 61, 1102-1111. (doi:10.1086/301608)
63. Wiuf, C. 2001 Do delta F508 heterozygotes have a selective advantage? Genet. Res. 78, 41-47. (doi:10.1017/ S0016672301005195)
64. Woods, R. & Shelton, N. 1997 An atlas of Victorian mortality. Liverpool, UK: Liverpool University Press.
65. Wrigley, E. A. & Schofield, R. S. 1981 The population history of England 1541-1871. Cambridge, MA: Harvard University Press.
66. Yamashiro, Y., Shimizu, T., Oguchi, S., Shioya, T., Nagata, S. & Ohtsuka, Y. 1997 The estimated incidence of cystic fibrosis in Japan. J. Pediatr. Gastroenterol. Nutr. 24, 544-547. (doi:10.1097/00005176- 199705000-00010)